PRQR
ProQR Therapeutics BVNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$151.72M
P/E Ratio
—
EPS
$-0.50
Beta
0.06
52W High
$3.10
52W Low
$1.33
50-Day MA
$1.63
200-Day MA
$1.93
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About ProQR Therapeutics BV
ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands.
Fundamentals
| Revenue (TTM) | $13.64M |
| Gross Profit (TTM) | $13.64M |
| EBITDA | $-45.36M |
| Operating Margin | -671.00% |
| Return on Equity | -78.10% |
| Return on Assets | -23.10% |
| Revenue/Share (TTM) | $0.13 |
| Book Value | $0.55 |
| Price-to-Book | 3.49 |
| Price-to-Sales (TTM) | 11.12 |
| EV/Revenue | 4.897 |
| EV/EBITDA | -2.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -57.10% |
| Shares Outstanding | $105.36M |
| Float | $64.35M |
| % Insiders | 17.66% |
| % Institutions | 48.94% |
Historical Volatility
HV 10-Day
70.80%
HV 20-Day
64.59%
HV 30-Day
66.29%
HV 60-Day
79.14%
HV Rank
33.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.88 target)
1
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026